# Treatment of Copper Intra Uterine Device Associated Heavy Menstrual Blood Loss

> **NCT03139422** · PHASE3 · UNKNOWN · sponsor: **Assiut University** · enrollment: 140 (estimated)

## Conditions studied

- Menorrhagia

## Interventions

- **DRUG:** Tranexamic Acid 500 MG
- **DRUG:** Calcium Dobesilate

## Key facts

- **NCT ID:** NCT03139422
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-01
- **Primary completion:** 2018-10
- **Final completion:** 2018-12
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2018-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03139422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03139422, "Treatment of Copper Intra Uterine Device Associated Heavy Menstrual Blood Loss". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03139422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*